Cargando…
Effect of early initiation of steroid-sparing drugs in patients with bullous pemphigoid
INTRODUCTION: Bullous pemphigoid (BP) can be treated using systemic and topical glucocorticoids and/or other immunomodulatory agents. However, the long-term use of systemic glucocorticoids causes severe adverse side effects. This study was aimed at investigating whether the early initiation of corti...
Autores principales: | Fenne, Inger Johanne, Askildsen Oftebro, Guro, Vestergaard, Christian, Frølunde, Anne Sofie, Bech, Rikke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358842/ https://www.ncbi.nlm.nih.gov/pubmed/37483611 http://dx.doi.org/10.3389/fimmu.2023.1176284 |
Ejemplares similares
-
Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature
por: Bech, Rikke, et al.
Publicado: (2018) -
Severe Infantile Bullous Pemphigoid Treated with Dapsone after Bridging with Systemic Glucocorticoid
por: Thomsen, Kenneth, et al.
Publicado: (2019) -
Biological treatment for bullous pemphigoid
por: Oren-Shabtai, Meital, et al.
Publicado: (2023) -
Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid
por: Koga, Hiroshi, et al.
Publicado: (2023) -
Side effects of steroid-sparing agents in patients with bullous pemphigoid and pemphigus: A systematic review
por: Zeng, Faith A.P., et al.
Publicado: (2022)